 NEW YORK, April 2, 2021 PRNewswire -- Juan Monteverde , founder and managing partner at Monteverde Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Millendo Therapeutics, Inc. MLND or the Company MLND relating to its proposed merger with Tempest Therapeutics, Inc. Under the terms of the agreement, MLND shareholders are expected to own 18.5 of the combined company. The investigation focuses on whether Millendo Therapeutics, Inc. and its Board of Directors violated securities laws andor breached their fiduciary duties to the Company by 1 failing to conduct a fair process, and 2 whether the transaction is properly valued. 